OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
Robert E. Boyd, Gary Lee, Philip J. Rybczynski, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 7, pp. 2705-2725
Closed Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
Giancarlo Parenti, Generoso Andria, Kenneth J. Valenzano
Molecular Therapy (2015) Vol. 23, Iss. 7, pp. 1138-1148
Open Access | Times Cited: 214

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
S. Pablo Sardi, Jesse M. Cedarbaum, Patrik Brundin
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 684-696
Open Access | Times Cited: 156

Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases
Elena M. Sánchez‐Fernández, José M. Garcı́a Fernández, Carmen Ortiz Mellet
Chemical Communications (2016) Vol. 52, Iss. 32, pp. 5497-5515
Open Access | Times Cited: 134

The Multivalent Effect in Glycosidase Inhibition: A New, Rapidly Emerging Topic in Glycoscience
Philippe Compain, Anne Bodlenner
ChemBioChem (2014) Vol. 15, Iss. 9, pp. 1239-1251
Closed Access | Times Cited: 105

Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations
Ludovica Liguori, Maria Monticelli, Mariateresa Allocca, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 489-489
Open Access | Times Cited: 102

Fabry Disease: The Current Treatment Landscape
Malte Lenders, Eva Brand
Drugs (2021) Vol. 81, Iss. 6, pp. 635-645
Open Access | Times Cited: 102

Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases
Marino Convertino, Jhuma Das, Nikolay V. Dokholyan
ACS Chemical Biology (2016) Vol. 11, Iss. 6, pp. 1471-1489
Closed Access | Times Cited: 99

GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies
Andrés Felipe Leal, Eliana Benincore-Flórez, Daniela Solano-Galarza, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6213-6213
Open Access | Times Cited: 95

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management
Kazuki Sawamoto, J. Víctor Álvarez, Matthew Piechnik, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1517-1517
Open Access | Times Cited: 92

Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
Kazuki Sawamoto, Molly Stapleton, Carlos Javier Alméciga-Díaz, et al.
Drugs (2019) Vol. 79, Iss. 10, pp. 1103-1134
Closed Access | Times Cited: 77

Pharmacological chaperoning: A primer on mechanism and pharmacology
Nancy J. Leidenheimer, Katelyn G. Ryder
Pharmacological Research (2014) Vol. 83, pp. 10-19
Open Access | Times Cited: 90

Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization
Anton Simeonov
Expert Opinion on Drug Discovery (2013) Vol. 8, Iss. 9, pp. 1071-1082
Open Access | Times Cited: 82

Innate and Adaptive Immune Response in Fabry Disease
Wladimir Mauhin, Olivier Lidove, Elisa Masat, et al.
JIMD Reports (2015), pp. 1-10
Open Access | Times Cited: 79

Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
David M. Pereira, Patrı́cia Valentão, Paula B. Andrade
Chemical Science (2018) Vol. 9, Iss. 7, pp. 1740-1752
Open Access | Times Cited: 79

Treatment of lysosomal storage disorders: successes and challenges
Carla E. M. Hollak, Frits A. Wijburg
Journal of Inherited Metabolic Disease (2014) Vol. 37, Iss. 4, pp. 587-598
Closed Access | Times Cited: 76

Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle
S. Pablo Sardi, Seng H. Cheng, Lamya S. Shihabuddin
Progress in Neurobiology (2015) Vol. 125, pp. 47-62
Open Access | Times Cited: 69

Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design
D. Sean Froese, Amit Michaeli, Thomas J. McCorvie, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 20, pp. 5667-5676
Open Access | Times Cited: 68

Potent Glycosidase Inhibition with Heterovalent Fullerenes: Unveiling the Binding Modes Triggering Multivalent Inhibition
Marta Abellán-Flos, M. Isabel García‐Moreno, Carmen Ortiz Mellet, et al.
Chemistry - A European Journal (2016) Vol. 22, Iss. 32, pp. 11450-11460
Closed Access | Times Cited: 67

pH‐Responsive Pharmacological Chaperones for Rescuing Mutant Glycosidases
Teresa Mena‐Barragán, Aya Narita, Dino Matias, et al.
Angewandte Chemie International Edition (2015) Vol. 54, Iss. 40, pp. 11696-11700
Closed Access | Times Cited: 65

Multivalent Effect in Glycosidase Inhibition: The End of the Beginning
Philippe Compain
The Chemical Record (2019) Vol. 20, Iss. 1, pp. 10-22
Closed Access | Times Cited: 63

Sphingolipid lysosomal storage diseases: from bench to bedside
Muna Abed Rabbo, Yara Khodour, Laurie S. Kaguni, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 42

A Systematic Investigation of Iminosugar Click Clusters as Pharmacological Chaperones for the Treatment of Gaucher Disease
Antoine Joosten, Camille Decroocq, Julien de Sousa, et al.
ChemBioChem (2013) Vol. 15, Iss. 2, pp. 309-319
Closed Access | Times Cited: 63

Pharmacological Chaperone Therapy for Lysosomal Storage Diseases
Giancarlo Parenti, Marco Moracci, Simona Fecarotta, et al.
Future Medicinal Chemistry (2014) Vol. 6, Iss. 9, pp. 1031-1045
Closed Access | Times Cited: 60

Are enzymes sensitive to the multivalent effect? Emerging evidence with glycosidases
Camilla Matassini, Camilla Parmeggiani, Francesca Cardona, et al.
Tetrahedron Letters (2016) Vol. 57, Iss. 49, pp. 5407-5415
Closed Access | Times Cited: 59

Page 1 - Next Page

Scroll to top